Function and role of microparticles in various clinical settings
- 1 January 2008
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 123 (1) , 8-23
- https://doi.org/10.1016/j.thromres.2008.06.006
Abstract
No abstract availableKeywords
This publication has 193 references indexed in Scilit:
- Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patientsThrombosis Research, 2008
- Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?Journal of Thrombosis and Haemostasis, 2007
- Role of platelet-derived chemokines (RANTES and ENA-78) after stem cell transplantationTransplant Immunology, 2006
- Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein deliveryLeukemia, 2006
- Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancerInternational Journal of Cancer, 2004
- Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb‐IIIa antagonistsJournal of Thrombosis and Haemostasis, 2004
- High levels of circulating endothelial microparticles in patients with acute coronary syndromesAmerican Heart Journal, 2003
- The Release Mechanism of Platelet-Activating Factor during Shear-Stress Induced Platelet AggregationBiochemical and Biophysical Research Communications, 1997
- The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharideBritish Journal of Haematology, 1997
- Platelet Microparticles: A Carrier of Platelet-Activating Factor?Biochemical and Biophysical Research Communications, 1996